Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis
Sulfasalazine is a well-established disease-modifying agent. It is commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. The most frequently reported adverse effects are gastrointestinal effects, headache, dizziness and rash; myelosuppression can also occur. Patients...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Enam Medical College, Dhaka
2016-09-01
|
Series: | Journal of Enam Medical College |
Subjects: | |
Online Access: | http://banglajol.info/index.php/JEMC/article/view/29685 |
_version_ | 1818691467873353728 |
---|---|
author | NS Neki Ankur Jain |
author_facet | NS Neki Ankur Jain |
author_sort | NS Neki |
collection | DOAJ |
description | Sulfasalazine is a well-established disease-modifying agent. It is commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. The most frequently reported adverse effects are gastrointestinal effects, headache, dizziness and rash; myelosuppression can also occur. Patients treated with sulfasalazine can develop thrombocytopenia which is immune mediated. We report a case of ulcerative colitis that was on sulfasalazine subsequently developing thrombocytopenia. |
first_indexed | 2024-12-17T12:42:22Z |
format | Article |
id | doaj.art-15ae15f39078475b961742316810920d |
institution | Directory Open Access Journal |
issn | 2227-6688 2304-9316 |
language | English |
last_indexed | 2024-12-17T12:42:22Z |
publishDate | 2016-09-01 |
publisher | Enam Medical College, Dhaka |
record_format | Article |
series | Journal of Enam Medical College |
spelling | doaj.art-15ae15f39078475b961742316810920d2022-12-21T21:47:55ZengEnam Medical College, DhakaJournal of Enam Medical College2227-66882304-93162016-09-016316416510.3329/jemc.v6i3.29685Sulfasalazine-Induced Pancytopenia in Ulcerative ColitisNS Neki0Ankur Jain1Professor, Department of Medicine, Government Medical College/Guru Nanak Dev Hospital, Amritsar, India Junior Resident, Department of Medicine, Government Medical College/Guru Nanak Dev Hospital, Amritsar, India Sulfasalazine is a well-established disease-modifying agent. It is commonly used in the treatment of rheumatic disorders and inflammatory bowel disease. The most frequently reported adverse effects are gastrointestinal effects, headache, dizziness and rash; myelosuppression can also occur. Patients treated with sulfasalazine can develop thrombocytopenia which is immune mediated. We report a case of ulcerative colitis that was on sulfasalazine subsequently developing thrombocytopenia.http://banglajol.info/index.php/JEMC/article/view/29685Sulfasalazine; Ulcerative colitis; Pancytopenia; Myelosuppression |
spellingShingle | NS Neki Ankur Jain Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis Journal of Enam Medical College Sulfasalazine; Ulcerative colitis; Pancytopenia; Myelosuppression |
title | Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis |
title_full | Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis |
title_fullStr | Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis |
title_full_unstemmed | Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis |
title_short | Sulfasalazine-Induced Pancytopenia in Ulcerative Colitis |
title_sort | sulfasalazine induced pancytopenia in ulcerative colitis |
topic | Sulfasalazine; Ulcerative colitis; Pancytopenia; Myelosuppression |
url | http://banglajol.info/index.php/JEMC/article/view/29685 |
work_keys_str_mv | AT nsneki sulfasalazineinducedpancytopeniainulcerativecolitis AT ankurjain sulfasalazineinducedpancytopeniainulcerativecolitis |